Combined ipsilateral treatment of cervical lymph nodes metastases from an unknown primary

被引:0
作者
Dequanter, D. [1 ]
Lothaire, P. [1 ]
Gastelblum, P. [2 ]
Nguyen, T. Hien [2 ]
Lalami, Y. [3 ]
Awada, A. [3 ]
Andry, G. [4 ]
机构
[1] CHU Charleroi, Dept Head & Neck & Thorac Surg, Montignies le Tilleul 6110, Belgium
[2] Inst Jules Bordet, Dept Radiotherapy, B-1000 Brussels, Belgium
[3] Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium
[4] Inst Jules Bordet, Dept Surg, B-1000 Brussels, Belgium
来源
B-ENT | 2008年 / 4卷 / 03期
关键词
Unknown primary; lymph node metastases; combined ipsilateral treatment; head and neck cancer;
D O I
暂无
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Introduction: The management of squamous cell carcinoma in undetermined primary tumours in the head and neck region (approximately 5.5% of patients) is controversial. Material and methods: The present report examines the outcomes for 14 patients after an initial treatment strategy directed principally at the side of the neck that is clinically involved. The distribution of nodal status was as follows: 1 N1. 8 N2A, 4 N2B, and 1 N3. Results: Initial treatment included a modified neck dissection in 12 cases and radical neck dissection in 2 cases, plus postoperative radiation in 10 cases. Radiotherapy was directed at the ipsilateral side of the neck alone. Concomitant radiochemotherapy was given in 2 cases. The rate of disease control on the ipsilateral side was 12/14. Two patients were treated by chemotherapy but died of their disease. The failure rate on the contralateral side wits 2/14. These two patients were Successfully salvaged. During follow-up, a primary tumour was detected in one case. At the end of the follow-up, 10 patients were alive. Conclusions: Modified radical neck dissection combined with postoperative radiation with or without chemotherapy could be considered in N1-N3 lymph node status. Despite generally advanced disease at presentation, patients presenting with cervical metastasis from an unknown primary carcinoma have a reasonable Survival expectation and aggressive treatment is warranted. Careful follow-up is required for effective salvage treatment.
引用
收藏
页码:157 / 161
页数:5
相关论文
共 17 条
  • [1] Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary
    Argiris, A
    Smith, SM
    Stenson, K
    Mittal, BB
    Pelzer, HJ
    Kies, MS
    Haraf, DJ
    Vokes, EE
    [J]. ANNALS OF ONCOLOGY, 2003, 14 (08) : 1306 - 1311
  • [2] Carcinoma metastatic to cervical lymph nodes from an occult primary tumor: The outcome after combined-modality therapy
    Boscolo-Rizzo, Paolo
    Gava, Alessandro
    Da Mosto, Maria Cristina
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (05) : 1575 - 1582
  • [3] Colletier PJ, 1998, HEAD NECK-J SCI SPEC, V20, P674, DOI 10.1002/(SICI)1097-0347(199812)20:8<674::AID-HED3>3.0.CO
  • [4] 2-H
  • [5] CERVICAL NODAL METASTASIS OF SQUAMOUS-CELL CARCINOMA OF UNKNOWN ORIGIN - INDICATIONS FOR WITHHOLDING RADIATION-THERAPY
    COSTER, JR
    FOOTE, RL
    OLSEN, KD
    JACK, SM
    SCHAID, DJ
    DESANTO, LW
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 23 (04): : 743 - 749
  • [6] Fernandez JA, 1998, CLIN OTOLARYNGOL, V23, P158
  • [7] Friesland S, 2001, ACTA ONCOL, V40, P24
  • [8] Cervical lymph node metastases from unknown primary tumours - Results from a national survey by the Danish Society for Head and Neck Oncology
    Grau, C
    Johansen, LV
    Jakobsen, J
    Geertsen, P
    Andersen, E
    Jensen, BB
    [J]. RADIOTHERAPY AND ONCOLOGY, 2000, 55 (02) : 121 - 129
  • [9] Metastatic squamous cell carcinoma of the neck from an unknown primary: Management options and patterns of relapse
    Iganej, S
    Kagan, R
    Anderson, P
    Rao, A
    Tome, M
    Wang, R
    Dowlatshahi, M
    Cosmatos, H
    Morgan, T
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (03): : 236 - 246
  • [10] Cervical lymph node metastases of squamous cell carcinoma from an unknown primary
    Jereczek-Fossa, BA
    Jassem, J
    Orecchia, R
    [J]. CANCER TREATMENT REVIEWS, 2004, 30 (02) : 153 - 164